Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 63

1.

Determinants of hydroxychloroquine blood concentration variation in systemic lupus erythematosus.

Jallouli M, Galicier L, Zahr N, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, Kahn JE, Pourrat J, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Leroux G, Cohen-Bittan J, Sellam J, Mariette X, Blanchet B, Hulot JS, Amoura Z, Piette JC, Costedoat-Chalumeau N; group PLUS.

Arthritis Rheumatol. 2015 May 18. doi: 10.1002/art.39194. [Epub ahead of print]

PMID:
25989906
2.

Cognitive demands during quiet standing elicit truncal tremor in two frequency bands: differential relations to tissue integrity of corticospinal tracts and cortical targets.

Sullivan EV, Zahr NM, Rohlfing T, Pfefferbaum A.

Front Hum Neurosci. 2015 Apr 7;9:175. doi: 10.3389/fnhum.2015.00175. eCollection 2015.

3.

Dynamic responses of selective brain white matter fiber tracts to binge alcohol and recovery in the rat.

Pfefferbaum A, Zahr NM, Mayer D, Rohlfing T, Sullivan EV.

PLoS One. 2015 Apr 20;10(4):e0124885. doi: 10.1371/journal.pone.0124885. eCollection 2015.

4.

Infliximab improves endothelial dysfunction in a mouse model of antiphospholipid syndrome: Role of reduced oxidative stress.

Benhamou Y, Miranda S, Armengol G, Harouki N, Drouot L, Zahr N, Thuillez C, Boyer O, Levesque H, Joannides R, Richard V.

Vascul Pharmacol. 2015 Apr 11. pii: S1537-1891(15)00059-2. doi: 10.1016/j.vph.2015.03.014. [Epub ahead of print]

PMID:
25869505
5.

Imaging neuroinflammation? A perspective from MR spectroscopy.

Zahr NM, Mayer D, Rohlfing T, Sullivan EV, Pfefferbaum A.

Brain Pathol. 2014 Nov;24(6):654-64. doi: 10.1111/bpa.12197.

PMID:
25345895
6.

Structural and microstructral imaging of the brain in alcohol use disorders.

Zahr NM.

Handb Clin Neurol. 2014;125:275-90. doi: 10.1016/B978-0-444-62619-6.00017-3.

PMID:
25307581
7.

Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib.

Idbaih A, Mokhtari K, Emile JF, Galanaud D, Belaid H, de Bernard S, Benameur N, Barlog VC, Psimaras D, Donadieu J, Carpentier C, Martin-Duverneuil N, Haroche J, Feuvret L, Zahr N, Delattre JY, Hoang-Xuan K.

Neurology. 2014 Oct 14;83(16):1478-80. doi: 10.1212/WNL.0000000000000880. Epub 2014 Sep 10. No abstract available.

PMID:
25209580
8.

Simultaneous determination of rivaroxaban and dabigatran levels in human plasma by high-performance liquid chromatography-tandem mass spectrometry.

Korostelev M, Bihan K, Ferreol L, Tissot N, Hulot JS, Funck-Brentano C, Zahr N.

J Pharm Biomed Anal. 2014 Nov;100:230-5. doi: 10.1016/j.jpba.2014.08.011. Epub 2014 Aug 15.

PMID:
25173108
9.

Development and validation of a rapid and simple LC-MS/MS method for quantification of vemurafenib in human plasma: application to a human pharmacokinetic study.

Bihan K, Sauzay C, Goldwirt L, Charbonnier-Beaupel F, Hulot JS, Funck-Brentano C, Zahr N.

Ther Drug Monit. 2015 Feb;37(1):132-6. doi: 10.1097/FTD.0000000000000110.

PMID:
24977381
10.

Associations between in vivo neuroimaging and postmortem brain cytokine markers in a rodent model of Wernicke's encephalopathy.

Zahr NM, Alt C, Mayer D, Rohlfing T, Manning-Bog A, Luong R, Sullivan EV, Pfefferbaum A.

Exp Neurol. 2014 Nov;261:109-19. doi: 10.1016/j.expneurol.2014.06.015. Epub 2014 Jun 25.

PMID:
24973622
11.

Analysis of placental vascularization in a pharmacological rabbit model of IUGR induced by L-NAME, a nitric oxide synthase inhibitor.

Tarrade A, Lecarpentier E, Gil S, Morel O, Zahr N, Dahirel M, Tsatsaris V, Chavatte-Palmer P.

Placenta. 2014 Apr;35(4):254-9. doi: 10.1016/j.placenta.2014.01.013. Epub 2014 Feb 6.

PMID:
24556056
12.

Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study.

Pfefferbaum A, Rogosa DA, Rosenbloom MJ, Chu W, Sassoon SA, Kemper CA, Deresinski S, Rohlfing T, Zahr NM, Sullivan EV.

Neurobiol Aging. 2014 Jul;35(7):1755-68. doi: 10.1016/j.neurobiolaging.2014.01.008. Epub 2014 Jan 13.

PMID:
24508219
13.

Urinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance.

Benz-de Bretagne I, Zahr N, Le Gouge A, Hulot JS, Houillier C, Hoang-Xuan K, Gyan E, Lissandre S, Choquet S, Le Guellec C.

Br J Clin Pharmacol. 2014 Aug;78(2):329-42. doi: 10.1111/bcp.12326.

PMID:
24433481
14.

Targeting chelatable iron as a therapeutic modality in Parkinson's disease.

Devos D, Moreau C, Devedjian JC, Kluza J, Petrault M, Laloux C, Jonneaux A, Ryckewaert G, Garçon G, Rouaix N, Duhamel A, Jissendi P, Dujardin K, Auger F, Ravasi L, Hopes L, Grolez G, Firdaus W, Sablonnière B, Strubi-Vuillaume I, Zahr N, Destée A, Corvol JC, Pöltl D, Leist M, Rose C, Defebvre L, Marchetti P, Cabantchik ZI, Bordet R.

Antioxid Redox Signal. 2014 Jul 10;21(2):195-210. doi: 10.1089/ars.2013.5593. Epub 2014 Feb 6.

15.

Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease.

Devos D, Lejeune S, Cormier-Dequaire F, Tahiri K, Charbonnier-Beaupel F, Rouaix N, Duhamel A, Sablonnière B, Bonnet AM, Bonnet C, Zahr N, Costentin J, Vidailhet M, Corvol JC.

Parkinsonism Relat Disord. 2014 Feb;20(2):170-5. doi: 10.1016/j.parkreldis.2013.10.017. Epub 2013 Oct 24.

PMID:
24216088
16.

Graphs of brain networks.

Zahr NM.

Alcohol Clin Exp Res. 2013 Nov;37(11):1813-5. doi: 10.1111/acer.12293.

PMID:
24164166
17.

Rat strain differences in brain structure and neurochemistry in response to binge alcohol.

Zahr NM, Mayer D, Rohlfing T, Hsu O, Vinco S, Orduna J, Luong R, Bell RL, Sullivan EV, Pfefferbaum A.

Psychopharmacology (Berl). 2014 Jan;231(2):429-45. doi: 10.1007/s00213-013-3253-z. Epub 2013 Sep 13.

18.

Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.

Jallouli M, Francès C, Piette JC, Huong du LT, Moguelet P, Factor C, Zahr N, Miyara M, Saadoun D, Mathian A, Haroche J, De Gennes C, Leroux G, Chapelon C, Wechsler B, Cacoub P, Amoura Z, Costedoat-Chalumeau N; Plaquenil LUpus Systemic Study Group.

JAMA Dermatol. 2013 Aug;149(8):935-40. doi: 10.1001/jamadermatol.2013.709.

PMID:
23824340
19.

Development of a new UPLC-MSMS method for the determination of temozolomide in mice: application to plasma pharmacokinetics and brain distribution study.

Goldwirt L, Zahr N, Farinotti R, Fernandez C.

Biomed Chromatogr. 2013 Jul;27(7):889-93. doi: 10.1002/bmc.2877. Epub 2013 Feb 25.

PMID:
23436249
20.

A mechanism of rapidly reversible cerebral ventricular enlargement independent of tissue atrophy.

Zahr NM, Mayer D, Rohlfing T, Orduna J, Luong R, Sullivan EV, Pfefferbaum A.

Neuropsychopharmacology. 2013 May;38(6):1121-9. doi: 10.1038/npp.2013.11. Epub 2013 Jan 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk